Description
Skin fine iso (Isotretinoin) 10 mg
Skin fine iso 10 mg is an oral isotretinoin capsule. Isotretinoin is a retinoid medicine used for severe, recalcitrant nodular acne when conventional acne treatments, including systemic antibiotics, have not been effective. The specific trade name “Skin fine iso” could not be independently verified from authoritative regulatory sources, so this page is based on the verified active ingredient, isotretinoin.
Active Ingredient and Medicine Class
The active ingredient is isotretinoin, a vitamin A–derived retinoid. It is a systemic anti-acne medicine that acts on several biological pathways involved in acne formation, including sebaceous gland activity and abnormal keratinisation.
Established Medical Uses
Oral isotretinoin is established for the treatment of severe recalcitrant nodular acne in non-pregnant patients. Regulatory labeling describes its use in patients 12 years of age and older with multiple inflammatory nodules and reserves it for disease that has not responded to conventional therapy, including systemic antibiotics.
It is not a general-purpose acne treatment and is typically considered when acne is severe, persistent, or associated with scarring or other significant burden.
How It Works
Isotretinoin is a retinoid whose exact mechanism in acne is not fully defined. Its clinical effect is linked to reduced sebaceous gland function, reduced sebum secretion, and reduced keratinisation within the pilosebaceous unit. By decreasing oil production and altering the environment that supports acne development, it can lead to improvement in severe nodular acne.
Important Safety Information
Isotretinoin has major safety restrictions because it can cause severe harm to an unborn baby. It is contraindicated in pregnancy and is supplied under a restricted distribution program designed to prevent embryo-fetal exposure. Hypersensitivity to isotretinoin, vitamin A, or product components is also a contraindication.
Clinically important precautions include psychiatric symptoms, intracranial hypertension, severe skin reactions, pancreatitis, lipid abnormalities, hepatotoxicity, inflammatory bowel disease, musculoskeletal effects, and ocular problems. Lipid and liver monitoring are part of standard prescribing information.
Important interactions include vitamin A supplements and tetracycline antibiotics, which should be avoided because they may increase adverse effects or risk of intracranial hypertension.
Possible Side Effects
Common adverse effects include dry lips, dry skin, chapped lips, dry eyes, back pain, joint pain, headache, nosebleeds, dermatitis, and upper respiratory symptoms. Laboratory abnormalities such as increased creatine kinase and lipid elevations can occur.
Serious adverse reactions may include severe birth defects with pregnancy exposure, pancreatitis, significant mood or psychiatric changes, intracranial hypertension, serious hypersensitivity reactions, liver injury, and marked lipid disturbances. Visual changes and decreased night vision are also recognised risks.
Scientific Evidence
Clinical and review literature consistently describes oral isotretinoin as one of the most effective therapies for severe acne, particularly nodular disease. Reviews also note that its benefits are associated with dose-related adverse effects, especially mucocutaneous dryness and laboratory abnormalities. Scientific discussion continues regarding optimal regimens, surveillance, and how to balance effectiveness with safety monitoring. These findings support its established role in severe acne, but they do not remove the need for careful patient selection and monitoring.
Medical Information Notice
This page is an educational summary based on sources available at the time of review. It does not replace the official patient leaflet, prescribing information, or individual assessment by a qualified healthcare professional.
Medical Sources
- U.S. Food and Drug Administration. Isotretinoin Capsule Information. Official safety and prescribing overview for isotretinoin. View official FDA source
- DailyMed / Zydus Pharmaceuticals USA Inc. Isotretinoin Capsules, Prescribing Information. Full prescribing information, including indications, contraindications, warnings, interactions, and adverse reactions. View prescribing information
- Afsaneh Sadeghzadeh-Bazargan et al. Systematic review of low-dose isotretinoin for treatment of acne vulgaris: Focus on indication, dosage, regimen, efficacy, safety, satisfaction, and follow up, based on clinical studies. Dermatologic Therapy, 2021. View scientific article
- Ramon Grimalt et al. Isotretinoin in the management of acne vulgaris: practical prescribing. International Journal of Dermatology, 2020. View scientific article
